产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 |
CAS No. |
50357-45-4 |
|---|---|
中文名称 |
4,4'-(戊烷-1,5-二基双(氧))二苯甲酰亚胺盐酸盐(2:1) |
英文名称 |
4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide dihydrochloride |
别名 |
PentaMidine-d4 2HCl;PentaMidine (dihydrochloride);4,4'-[1,5-Pentanediylbis(oxy)]bisbenzenecarboximidamide] dihydrochloride;Benzenecarboximidamide, 4,4'-[1,5-pentanediylbis(oxy)]bis-, dihydrochloride (9CI);MP601205 dihydrochloride;MP601205 DIHYDROCHLORIDE;PENTAMIDINE;PTP1B,Pneumocystis,Parasite,Antibiotic,antitumor,Pentamidine,MP 601205,Inhibitor,Kidney,MP-601205,carinii,Bacterial,cell-cycle,pneumonia,MP601205,Phosphatase,inhibit,DNA,Pentamidine dihydrochloride,biosynthetics,Fungal,arrest;Pentamidine dihydrochloride, 10 mM in DMSO |
标准英文名 |
4,4'-(pentane-1,5-diylbis(oxy))dibenzimidamide dihydrochloride |
分子式 |
C19H26Cl2N4O2 |
分子量 |
413.35 |
精确分子量 |
412.14 |
SMILES |
N=C(N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1.[H]Cl.[H]Cl |
标准SMILES |
Cl.Cl.NC(=N)C1C=CC(=CC=1)OCCCCCOC1C=CC(=CC=1)C(N)=N |
用途 |
Pentamidine dihydrochloride is used for the treatment of visceral leishmaniasis (kala-azar) in patients who are unresponsive to or intolerant of antimony-based therapy, including those with antimony allergy or antimony-induced granulocytopenia; it exhibits antiprotozoal activity against Leishmania infantum (IC50 = 2.5 μM) by interfering with glycolysis and DNA biosynthesis; it is also investigated for the treatment of Pneumocystis pneumonia (PCP), African trypanosomiasis (particularly Trypanosoma brucei gambiense infection), and antimony-resistant leishmaniasis; additionally, it demonstrates antitumor activity by inhibiting cancer cell growth in a concentration-dependent manner, inducing cell-cycle arrest at the G2/M phase, and promoting programmed cell death; it acts as a potent and selective inhibitor of protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL). |
InChIKey |
HWURPQUPKQFGJI-UHFFFAOYSA-N |
|
|
评论 |
|---|